Kudo M - Search Results

1

Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

Inuzuka T, Nishikawa H, Sekikawa A, Takeda H, Henmi S, Sakamoto A, Saito S, Kita R, Kimura T, Osaki Y, Kudo M. Inuzuka T, et al. Among authors: kudo m. Oncology. 2011;81 Suppl 1:152-7. doi: 10.1159/000333279. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212950

2

Imaging blood flow characteristics of hepatocellular carcinoma.

Kudo M. Kudo M. Oncology. 2002;62 Suppl 1:48-56. doi: 10.1159/000048276. Oncology. 2002. PMID: 11868785

3

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Kudo M, Chung H, Osaki Y. Kudo M, et al. J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038. J Gastroenterol. 2003. PMID: 12673442 Review.

4

Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel.

Chung H, Kudo M, Kumada T, Katsushima S, Okano A, Nakamura T, Osaki Y, Kohigashi K, Yamashita Y, Komori H, Nishiuma S. Chung H, et al. Among authors: kudo m. J Gastroenterol. 2003;38(9):877-9. doi: 10.1007/s00535-003-1156-1. J Gastroenterol. 2003. PMID: 14569445

5

Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kudo M, et al. Hepatology. 2004 Dec;40(6):1396-405. doi: 10.1002/hep.20486. Hepatology. 2004. PMID: 15565571

6

[Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].

Kudo M, Chung H, Osaki Y, Kasugai H, Oka H, Seki T. Kudo M, et al. Gan To Kagaku Ryoho. 2004 Dec;31(13):2100-4. Gan To Kagaku Ryoho. 2004. PMID: 15628751 Review. Japanese.

7

Early detection and curative treatment of early-stage hepatocellular carcinoma.

Kudo M. Kudo M. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S144-8. doi: 10.1016/s1542-3565(05)00712-3. Clin Gastroenterol Hepatol. 2005. PMID: 16234064 Review.

8

A proposal of the modified liver damage classification for hepatocellular carcinoma.

Chung H, Kudo M, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y. Chung H, et al. Among authors: kudo m. Hepatol Res. 2006 Feb;34(2):124-9. doi: 10.1016/j.hepres.2005.10.009. Epub 2005 Dec 27. Hepatol Res. 2006. PMID: 16377236

9

Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers.

Hagiwara S, Kudo M, Minami Y, Chung H, Nakatani T, Fukunaga T, Osaki Y, Yamashita Y, Kajimura K. Hagiwara S, et al. Among authors: kudo m. Intervirology. 2006;49(4):200-6. doi: 10.1159/000090789. Epub 2006 Jan 11. Intervirology. 2006. PMID: 16407657

10

Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.

Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T. Toyoda H, et al. Among authors: kudo m. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1528-36. doi: 10.1016/j.cgh.2006.09.021. Clin Gastroenterol Hepatol. 2006. PMID: 17162244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,562 results

Search Page

Filters